These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14551132)

  • 1. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.
    Chen BJ; Cui X; Sempowski GD; Liu C; Chao NJ
    Blood; 2004 Feb; 103(4):1534-41. PubMed ID: 14551132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.
    Zhang J; Barefoot BE; Mo W; Deoliveira D; Son J; Cui X; Ramsburg E; Chen BJ
    Blood; 2012 Jun; 119(26):6344-53. PubMed ID: 22596261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-reactive CD8+ memory stem cells in graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    Nat Med; 2005 Dec; 11(12):1299-305. PubMed ID: 16288282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naive and memory T cells induce different types of graft-versus-host disease.
    Dutt S; Tseng D; Ermann J; George TI; Liu YP; Davis CR; Fathman CG; Strober S
    J Immunol; 2007 Nov; 179(10):6547-54. PubMed ID: 17982043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.
    Foster AE; Marangolo M; Sartor MM; Alexander SI; Hu M; Bradstock KF; Gottlieb DJ
    Blood; 2004 Oct; 104(8):2403-9. PubMed ID: 15231569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory CD4+ T cells do not induce graft-versus-host disease.
    Anderson BE; McNiff J; Yan J; Doyle H; Mamula M; Shlomchik MJ; Shlomchik WD
    J Clin Invest; 2003 Jul; 112(1):101-8. PubMed ID: 12840064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors.
    Sheng-Tanner X; McKerlie C; Spaner D
    Transplantation; 2000 Dec; 70(12):1683-93. PubMed ID: 11152097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.
    Florek M; Schneidawind D; Pierini A; Baker J; Armstrong R; Pan Y; Leveson-Gower D; Negrin R; Meyer E
    PLoS One; 2015; 10(12):e0145763. PubMed ID: 26693907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets.
    Stelljes M; Strothotte R; Pauels HG; Poremba C; Milse M; Specht C; Albring J; Bisping G; Scheffold C; Kammertoens T; Oelmann E; Silling G; Berdel WE; Kienast J
    Blood; 2004 Aug; 104(4):1210-6. PubMed ID: 15090450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
    Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
    Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of lymph node fibroblastic reticular cells and high endothelial cells is associated with humoral immunodeficiency in mouse graft-versus-host disease.
    Suenaga F; Ueha S; Abe J; Kosugi-Kanaya M; Wang Y; Yokoyama A; Shono Y; Shand FH; Morishita Y; Kunisawa J; Sato S; Kiyono H; Matsushima K
    J Immunol; 2015 Jan; 194(1):398-406. PubMed ID: 25422510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.
    Anderson BE; Taylor PA; McNiff JM; Jain D; Demetris AJ; Panoskaltsis-Mortari A; Ager A; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2008 May; 111(10):5242-51. PubMed ID: 18285547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of IL-2-unresponsive allogeneic T cells in sublethally irradiated SCID mice.
    Spaner D; Sheng-Tanner X; Raju K; Rabinovich B; Messner H; Miller RG
    Int Immunol; 1999 Oct; 11(10):1601-14. PubMed ID: 10508178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL; Forman J
    J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.
    Chen BJ; Deoliveira D; Cui X; Le NT; Son J; Whitesides JF; Chao NJ
    Blood; 2007 Apr; 109(7):3115-23. PubMed ID: 17148592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
    Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
    Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.